The publications on this site are part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726

Informa
Skip to Page Content

Companies

Search All Companies »

Find a Company by Name

View All Companies

All
Industries

Biotechnology

Email Alert | RSS Feed

Semma Therapeutics Inc. / See Company Profile

Acquisition / Vertex pays $950mm for diabetes-focused Semma / Strategic Transactions / Deal Date: Sep. 1, 2019 / Publish Date: Sep. 4, 2019

Financing / Semma's Series B brings in $114mm / Strategic Transactions / Deal Date: Nov. 1, 2017 / Publish Date: Dec. 1, 2017

Alliance / Novartis teams up with diabetes start-up Semma Therapeutics / Strategic Transactions / Deal Date: Mar. 1, 2015 / Publish Date: Mar. 25, 2015

SpringWorks Therapeutics Inc. / See Company Profile

Financing / SpringWorks nets $150.7mm via IPO / Strategic Transactions / Deal Date: Sep. 1, 2019 / Publish Date: Sep. 16, 2019

Alliance / Pfizer invests in, licenses four clinical-stage assets to SpringWorks / Strategic Transactions / Deal Date: Sep. 1, 2017 / Update Date: Jun. 1, 2019

Financing / SpringWorks raises $125mm in Series B round / Strategic Transactions / Deal Date: Apr. 1, 2019 / Publish Date: Apr. 2, 2019

Cidara Therapeutics Inc. / See Company Profile

Alliance / Mundipharma gets license to Cidara's antifungal rezafungin / Strategic Transactions / Deal Date: Sep. 1, 2019 / Publish Date: Sep. 4, 2019

Financing / Cidara nets $19mm via PIPE / Strategic Transactions / Deal Date: Oct. 1, 2017 / Publish Date: Oct. 20, 2017

Financing / Cidara enters $20mm credit facility with Square 1 Bank / Strategic Transactions / Deal Date: Nov. 1, 2016 / Publish Date: Nov. 3, 2016


Medical Devices

Email Alert | RSS Feed

Clearside Biomedical Inc. / See Company Profile

Alliance / REGENXBIO gets option to Clearside Biomedical’s SCS Microinjector / Strategic Transactions / Deal Date: Sep. 1, 2019 / Publish Date: Sep. 6, 2019

Alliance / Aura gets global rights to Clearside's microinjector / Strategic Transactions / Deal Date: Jul. 1, 2019 / Publish Date: Jul. 10, 2019

Financing / Clearside nets $79.9mm via FOPO / Strategic Transactions / Deal Date: Mar. 1, 2018 / Publish Date: Mar. 10, 2018

Corindus Vascular Robotics Inc. / See Company Profile

Acquisition / Siemens Healthineers buys Corindus Vascular for $1.1bn / Strategic Transactions / Deal Date: Aug. 1, 2019 / Publish Date: Aug. 9, 2019

Financing / Corindus Vascular Robotics nets $14.8mm via PIPE; adds another $4.7mm / Strategic Transactions / Deal Date: Feb. 1, 2019 / Update Date: Mar. 1, 2019

Financing / Corindus closes private placement of preferred shares and enters debt agreement / Strategic Transactions / Deal Date: Mar. 1, 2018 / Publish Date: Mar. 16, 2018

Cheetah Medical Inc. / See Company Profile

Acquisition / Baxter enhances patient monitoring offerings through Cheetah Medical buy / Strategic Transactions / Deal Date: Sep. 1, 2019 / Publish Date: Sep. 11, 2019

Financing / Cheetah Medical brings in $14.5mm through its Series C financing; closes round at $40.6mm / Strategic Transactions / Deal Date: Mar. 1, 2013 / Update Date: Sep. 1, 2017

Financing / Cheetah Medical raises $20mm through its Series B / Strategic Transactions / Deal Date: Mar. 1, 2010 / Publish Date: Apr. 1, 2010


In Vitro Diagnostics

Email Alert | RSS Feed

Chembio Diagnostics Inc. / See Company Profile

Financing / Chembio enters $20mm term loan with Perceptive Advisors / Strategic Transactions / Deal Date: Sep. 1, 2019 / Publish Date: Sep. 11, 2019

Financing / Chembio nets $15mm via FOPO / Strategic Transactions / Deal Date: Nov. 1, 2018 / Publish Date: Nov. 2, 2018

Financing / Chembio Diagnostics nets $11.2mm via FOPO / Strategic Transactions / Deal Date: Feb. 1, 2018 / Publish Date: Feb. 14, 2018

Curetis NV / See Company Profile

Acquisition / Curetis, OpGen merge / Strategic Transactions / Deal Date: Sep. 1, 2019 / Publish Date: Sep. 5, 2019

Financing / Curetis secures up to €20mm in convertible debt financing / Strategic Transactions / Deal Date: Oct. 1, 2018 / Update Date: May 1, 2019

Alliance / A. Menarini gets license to Curetis' Unyvero platform / Strategic Transactions / Deal Date: Mar. 1, 2019 / Publish Date: Mar. 27, 2019

Genomic Health Inc. / See Company Profile

Acquisition / Exact Sciences and Genomic Health merge in $2.8bn deal / Strategic Transactions / Deal Date: Jul. 1, 2019 / Publish Date: Jul. 30, 2019

Alliance / Genomic Health develops Oncotype DX test for breast cancer on Biocartis' Idylla system; prostate cancer added / Strategic Transactions / Deal Date: Sep. 1, 2017 / Update Date: Dec. 1, 2018

Alliance / Genomic Health gets exclusive rights to sell Epic's liquid biopsy test in the US / Strategic Transactions / Deal Date: Jul. 1, 2016 / Publish Date: Aug. 24, 2016


Pharmaceuticals

Email Alert | RSS Feed

KemPharm Inc. / See Company Profile

Alliance / KemPharm licenses ADHD compounds to VC firm Gurnet Point Capital / Strategic Transactions / Deal Date: Sep. 1, 2019 / Publish Date: Sep. 6, 2019

Alliance / KVK gains US rights to KemPharm's Apadaz / Strategic Transactions / Deal Date: Oct. 1, 2018 / Publish Date: Nov. 2, 2018

Financing / KemPharm nets $23.5mm in FOPO / Strategic Transactions / Deal Date: Oct. 1, 2018 / Publish Date: Oct. 11, 2018

Celyad SA / See Company Profile

Financing / Public offering nets $18.8mm for Celyad / Strategic Transactions / Deal Date: Sep. 1, 2019 / Publish Date: Sep. 13, 2019

Acquisition / Cardio3 BioSciences SA acquires OnCyte LLC from Celdara Medical LLC / Strategic Transactions / Deal Date: Jan. 1, 2015 / Update Date: Aug. 1, 2017

Alliance / Celyad licenses CAR-T patents to Novartis / Strategic Transactions / Deal Date: May 1, 2017 / Publish Date: May 4, 2017

Angelini SPA / See Company Profile

Alliance / Angelini buys two OTC brands from Sanofi, pays €47mm / Strategic Transactions / Deal Date: Aug. 1, 2019 / Publish Date: Sep. 3, 2019

Alliance / Angelini to sell Durata’s antibiotic dalbavancin in 36 European countries / Strategic Transactions / Deal Date: Jul. 1, 2014 / Update Date: Mar. 1, 2015

Alliance / Angelini/CSC Pharmaceuticals to sell Ariad's Iclusig in Central and Eastern European countries / Strategic Transactions / Deal Date: Dec. 1, 2014 / Publish Date: Jan. 5, 2015

Biotechnology

Biotechnology

Email Alert | RSS Feed

Semma Therapeutics Inc. / See Company Profile

Acquisition / Vertex pays $950mm for diabetes-focused Semma / Strategic Transactions / Deal Date: Sep. 1, 2019 / Publish Date: Sep. 4, 2019

Financing / Semma's Series B brings in $114mm / Strategic Transactions / Deal Date: Nov. 1, 2017 / Publish Date: Dec. 1, 2017

Alliance / Novartis teams up with diabetes start-up Semma Therapeutics / Strategic Transactions / Deal Date: Mar. 1, 2015 / Publish Date: Mar. 25, 2015

SpringWorks Therapeutics Inc. / See Company Profile

Financing / SpringWorks nets $150.7mm via IPO / Strategic Transactions / Deal Date: Sep. 1, 2019 / Publish Date: Sep. 16, 2019

Alliance / Pfizer invests in, licenses four clinical-stage assets to SpringWorks / Strategic Transactions / Deal Date: Sep. 1, 2017 / Update Date: Jun. 1, 2019

Financing / SpringWorks raises $125mm in Series B round / Strategic Transactions / Deal Date: Apr. 1, 2019 / Publish Date: Apr. 2, 2019

Cidara Therapeutics Inc. / See Company Profile

Alliance / Mundipharma gets license to Cidara's antifungal rezafungin / Strategic Transactions / Deal Date: Sep. 1, 2019 / Publish Date: Sep. 4, 2019

Financing / Cidara nets $19mm via PIPE / Strategic Transactions / Deal Date: Oct. 1, 2017 / Publish Date: Oct. 20, 2017

Financing / Cidara enters $20mm credit facility with Square 1 Bank / Strategic Transactions / Deal Date: Nov. 1, 2016 / Publish Date: Nov. 3, 2016

Medical
Devices

Medical Devices

Email Alert | RSS Feed

Clearside Biomedical Inc. / See Company Profile

Alliance / REGENXBIO gets option to Clearside Biomedical’s SCS Microinjector / Strategic Transactions / Deal Date: Sep. 1, 2019 / Publish Date: Sep. 6, 2019

Alliance / Aura gets global rights to Clearside's microinjector / Strategic Transactions / Deal Date: Jul. 1, 2019 / Publish Date: Jul. 10, 2019

Financing / Clearside nets $79.9mm via FOPO / Strategic Transactions / Deal Date: Mar. 1, 2018 / Publish Date: Mar. 10, 2018

Corindus Vascular Robotics Inc. / See Company Profile

Acquisition / Siemens Healthineers buys Corindus Vascular for $1.1bn / Strategic Transactions / Deal Date: Aug. 1, 2019 / Publish Date: Aug. 9, 2019

Financing / Corindus Vascular Robotics nets $14.8mm via PIPE; adds another $4.7mm / Strategic Transactions / Deal Date: Feb. 1, 2019 / Update Date: Mar. 1, 2019

Financing / Corindus closes private placement of preferred shares and enters debt agreement / Strategic Transactions / Deal Date: Mar. 1, 2018 / Publish Date: Mar. 16, 2018

Cheetah Medical Inc. / See Company Profile

Acquisition / Baxter enhances patient monitoring offerings through Cheetah Medical buy / Strategic Transactions / Deal Date: Sep. 1, 2019 / Publish Date: Sep. 11, 2019

Financing / Cheetah Medical brings in $14.5mm through its Series C financing; closes round at $40.6mm / Strategic Transactions / Deal Date: Mar. 1, 2013 / Update Date: Sep. 1, 2017

Financing / Cheetah Medical raises $20mm through its Series B / Strategic Transactions / Deal Date: Mar. 1, 2010 / Publish Date: Apr. 1, 2010

In Vitro
Diagnostics

In Vitro Diagnostics

Email Alert | RSS Feed

Chembio Diagnostics Inc. / See Company Profile

Financing / Chembio enters $20mm term loan with Perceptive Advisors / Strategic Transactions / Deal Date: Sep. 1, 2019 / Publish Date: Sep. 11, 2019

Financing / Chembio nets $15mm via FOPO / Strategic Transactions / Deal Date: Nov. 1, 2018 / Publish Date: Nov. 2, 2018

Financing / Chembio Diagnostics nets $11.2mm via FOPO / Strategic Transactions / Deal Date: Feb. 1, 2018 / Publish Date: Feb. 14, 2018

Curetis NV / See Company Profile

Acquisition / Curetis, OpGen merge / Strategic Transactions / Deal Date: Sep. 1, 2019 / Publish Date: Sep. 5, 2019

Financing / Curetis secures up to €20mm in convertible debt financing / Strategic Transactions / Deal Date: Oct. 1, 2018 / Update Date: May 1, 2019

Alliance / A. Menarini gets license to Curetis' Unyvero platform / Strategic Transactions / Deal Date: Mar. 1, 2019 / Publish Date: Mar. 27, 2019

Genomic Health Inc. / See Company Profile

Acquisition / Exact Sciences and Genomic Health merge in $2.8bn deal / Strategic Transactions / Deal Date: Jul. 1, 2019 / Publish Date: Jul. 30, 2019

Alliance / Genomic Health develops Oncotype DX test for breast cancer on Biocartis' Idylla system; prostate cancer added / Strategic Transactions / Deal Date: Sep. 1, 2017 / Update Date: Dec. 1, 2018

Alliance / Genomic Health gets exclusive rights to sell Epic's liquid biopsy test in the US / Strategic Transactions / Deal Date: Jul. 1, 2016 / Publish Date: Aug. 24, 2016

Pharmaceuticals

Pharmaceuticals

Email Alert | RSS Feed

KemPharm Inc. / See Company Profile

Alliance / KemPharm licenses ADHD compounds to VC firm Gurnet Point Capital / Strategic Transactions / Deal Date: Sep. 1, 2019 / Publish Date: Sep. 6, 2019

Alliance / KVK gains US rights to KemPharm's Apadaz / Strategic Transactions / Deal Date: Oct. 1, 2018 / Publish Date: Nov. 2, 2018

Financing / KemPharm nets $23.5mm in FOPO / Strategic Transactions / Deal Date: Oct. 1, 2018 / Publish Date: Oct. 11, 2018

Celyad SA / See Company Profile

Financing / Public offering nets $18.8mm for Celyad / Strategic Transactions / Deal Date: Sep. 1, 2019 / Publish Date: Sep. 13, 2019

Acquisition / Cardio3 BioSciences SA acquires OnCyte LLC from Celdara Medical LLC / Strategic Transactions / Deal Date: Jan. 1, 2015 / Update Date: Aug. 1, 2017

Alliance / Celyad licenses CAR-T patents to Novartis / Strategic Transactions / Deal Date: May 1, 2017 / Publish Date: May 4, 2017

Angelini SPA / See Company Profile

Alliance / Angelini buys two OTC brands from Sanofi, pays €47mm / Strategic Transactions / Deal Date: Aug. 1, 2019 / Publish Date: Sep. 3, 2019

Alliance / Angelini to sell Durata’s antibiotic dalbavancin in 36 European countries / Strategic Transactions / Deal Date: Jul. 1, 2014 / Update Date: Mar. 1, 2015

Alliance / Angelini/CSC Pharmaceuticals to sell Ariad's Iclusig in Central and Eastern European countries / Strategic Transactions / Deal Date: Dec. 1, 2014 / Publish Date: Jan. 5, 2015

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel

Email Alert



  or Cancel

Create Your Customized RSS Feed



  or Cancel